DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Arterial Calcification - Pipeline Review, H1 2016" report to their offering.
This report provides comprehensive information on the therapeutic development for Arterial Calcification, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Arterial Calcification) and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Arterial Calcification Overview
- Therapeutics Development
- Pipeline Products for Arterial Calcification - Overview
- Pipeline Products for Arterial Calcification - Comparative Analysis
- Arterial Calcification - Therapeutics under Development by Companies
- Arterial Calcification - Therapeutics under Investigation by Universities/Institutes
- Arterial Calcification Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Arterial Calcification - Products under Development by Companies
- Arterial Calcification - Products under Investigation by Universities/Institutes
- Arterial Calcification - Companies Involved in Therapeutics Development
- Alexion Pharmaceuticals, Inc.
- Medestea Research & Production S.p.A.
For more information visit http://www.researchandmarkets.com/research/5bd92n/arterial